Data through Oct 29, 2026 Snapshot Oct 29, 7:00 PM ET
VVOS
VVOS
Vivos Therapeutics
$0.12
−$1.38(−91.87%)•
Gene's position
Shares6,666.6667
Cost basis$10,000.00
Bought at$1.50
Last close$0.12
Current value$813.33
Total return−91.87%
About
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormal…